GEMAYEL GEORGES bought SUPN
February 23, 2026 · Form 4 insider transaction
GEMAYEL GEORGES bought 15,000 shares of Supernus Pharmaceuticals, Inc. at $12.98 per share, a transaction worth $194.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
15,000
Price
$12.98
Total value
$194.7K
InsiderGEMAYEL GEORGES
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 23, 2026
Filing dateFebruary 25, 2026
Shares owned after33,684
OwnershipDirect
10b5-1 planNo
AmendedNo